class name | count |
---|---|
asterids | 29 |
rosids | 4 |
class name | count |
---|---|
Apocynaceae | 22 |
Plantaginaceae | 7 |
Brassicaceae | 4 |
br08003 Category | # of metabolite |
---|---|
Cardanolide | 7 |
br08003 Category | KEGG ID | KNApSAcK ID |
---|---|---|
Cardanolide | C08861 | C00003615 |
Cardanolide | C08862 | C00003616 |
Cardanolide | C06955 | C00003617 |
Cardanolide | C06956 | C00003618 |
Cardanolide | C08866 | C00003622 |
Cardanolide | C08881 | C00003638 |
Cardanolide | C08882 | C00003639 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00003610
![]() |
Cerberoside
|
CHEMBL263601
|
![]() |
|||
C00003615
![]() |
Diginatin
|
CHEMBL112842
|
![]() |
|||
C00003616
![]() |
Digitalin
/ Digitalinum verum / Schmiedeberg's digitalin |
CHEMBL505674
|
C034791
|
0 / 1 |
![]() |
|
C00003617
![]() |
Digitoxin
|
CHEMBL267817
CHEMBL254219 CHEMBL1324812 CHEMBL1899295 |
D004074
|
124 / 85 / 86 | 22 / 43 |
![]() |
C00003618
![]() |
Digoxin
|
CHEMBL1751
CHEMBL1477182 CHEMBL1512361 |
D004077
|
139 / 97 / 93 | 15 / 106 |
![]() |
C00003622
![]() |
Gitoxin
|
CHEMBL109317
CHEMBL137281 CHEMBL2069121 |
C005003
|
15 / 29 / 19 |
![]() |
|
C00003638
![]() |
K-strophanthoside
|
CHEMBL447086
|
C008240
|
![]() |
||
C00003639
![]() |
Thevetin A
|
![]() |
||||
C00032810
![]() |
Cheiranthoside IX
|
CHEMBL1169677
|
![]() |
|||
C00032811
![]() |
Cheiranthoside X
|
![]() |
||||
C00034104
![]() |
Periforoside I
/ (+)-Periforoside I |
![]() |
||||
C00034109
![]() |
Periplocin
|
![]() |
||||
C00036957
![]() |
Cryptostigmin I
|
![]() |
||||
C00036958
![]() |
Cryptostigmin II
|
![]() |
||||
C00036959
![]() |
Cryptostigmin III
/ (-)-Cryptostigmin III |
![]() |
||||
C00036960
![]() |
Cryptostigmin IV
|
![]() |
||||
C00038612
![]() |
Boivinide A
|
CHEMBL400632
|
![]() |
|||
C00038613
![]() |
Boivinide B
|
CHEMBL398881
CHEMBL251691 |
![]() |
|||
C00038614
![]() |
Boivinide C
|
![]() |
||||
C00038615
![]() |
Boivinide D
|
CHEMBL249844
|
![]() |
|||
C00038616
![]() |
Boivinide E
|
![]() |
||||
C00038617
![]() |
Boivinide F
|
CHEMBL398874
|
![]() |
|||
C00040916
![]() |
Cheiranthoside IV
/ (+)-Cheiranthoside IV |
![]() |
||||
C00040917
![]() |
Cheiranthoside V
/ (+)-Cheiranthoside V |
![]() |
||||
C00041275
![]() |
3'-O-beta-D-glucopyranosylcalactin
/ (+)-3'-O-beta-D-glucopyranosylcalactin |
CHEMBL508988
CHEMBL555674 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q16637 | Survival motor neuron protein | Unclassified protein | C00003617 C00003618 C00003622 | 4 / 1 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00003617 C00003618 C00003622 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00003617 C00003618 C00003622 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00003617 C00003618 C00003622 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00003617 C00003618 C00003622 | 2 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00003617 C00003618 C00003622 | 1 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00003617 C00003618 C00003622 | 11 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00003617 C00003618 | 1 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00003617 C00003618 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00003617 C00003618 | 0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00003617 C00003618 | 2 / 2 |
P54709 | Sodium/potassium-transporting ATPase subunit beta-3 | potassium_sodium | C00003617 C00003618 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00003617 C00003618 | 2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00003617 C00003618 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00003617 C00003618 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00003617 C00003618 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00003617 C00003618 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00003617 C00003618 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00003617 C00003618 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00003617 C00003618 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00003617 C00003618 | 2 / 2 |
P54710 | Sodium/potassium-transporting ATPase subunit gamma | potassium_sodium | C00003617 C00003618 | 1 / 1 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00003617 C00003622 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003618 C00003622 | 2 / 0 |
Q13733 | Sodium/potassium-transporting ATPase subunit alpha-4 | Hydrolase | C00003617 C00003618 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00003617 C00003618 | 3 / 1 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00003617 C00003618 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00003617 C00003618 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00003617 C00003618 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00003617 C00003618 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00003617 C00003618 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00003617 C00003618 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00003617 C00003618 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00003617 C00003618 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00003617 C00003618 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00003617 C00003618 | 0 / 0 |
P13637 | Sodium/potassium-transporting ATPase subunit alpha-3 | Hydrolase | C00003617 C00003618 | 2 / 1 |
P08183 | Multidrug resistance protein 1 | drug | C00003617 C00003618 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00003617 C00003618 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00003617 C00003618 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00003617 C00003618 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003617 C00003618 | 0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00003617 C00003618 | 1 / 8 |
P14415 | Sodium/potassium-transporting ATPase subunit beta-2 | potassium_sodium | C00003617 C00003618 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00003617 C00003618 | 2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00003617 C00003618 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00003617 C00003618 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00003617 C00003618 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00003617 C00003618 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00003617 C00003618 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00003617 C00003618 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00003617 C00003618 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00003617 C00003618 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00003617 C00003618 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00003617 C00003618 | 1 / 0 |
P05023 | Sodium/potassium-transporting ATPase subunit alpha-1 | Hydrolase | C00003617 C00003618 | 0 / 0 |
Q6ZQN7 | Solute carrier organic anion transporter family member 4C1 | Unclassified protein | C00003617 C00003618 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00003617 C00003618 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00003618 C00003622 | 1 / 1 |
P50993 | Sodium/potassium-transporting ATPase subunit alpha-2 | Hydrolase | C00003617 C00003618 | 2 / 2 |
P05026 | Sodium/potassium-transporting ATPase subunit beta-1 | potassium_sodium | C00003617 C00003618 | 0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00003617 C00003618 | 0 / 0 |
P42224 | Signal transducer and activator of transcription 1-alpha/beta | Unclassified protein | C00003617 C00003618 | 3 / 3 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00003617 C00003618 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00003617 C00003618 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00003617 C00003618 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00003617 C00003618 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00003617 C00003618 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00003617 C00003618 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00003617 C00003618 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00003617 C00003618 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00003617 C00003618 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00003617 C00003618 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00003617 C00003618 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00003617 C00003618 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00003617 C00003618 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00003617 C00003618 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00003617 C00003618 | 1 / 0 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00003617 C00003618 | 1 / 2 |
P06239 | Tyrosine-protein kinase Lck | Src | C00003617 C00003618 | 0 / 1 |
P03956 | Interstitial collagenase | M10A | C00003617 C00003618 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00003617 C00003618 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00003617 C00003618 | 1 / 1 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00003617 C00003618 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00003617 C00003618 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00003617 C00003618 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00003617 C00003618 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00003617 C00003618 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00003617 C00003618 | 2 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00003617 C00003618 | 5 / 3 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00003617 C00003618 | 5 / 9 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00003617 C00003618 | 0 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00003617 C00003618 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00003617 C00003618 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00003617 C00003618 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00003617 C00003618 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00003617 C00003618 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00003617 C00003618 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00003617 C00003618 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00003617 C00003618 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00003617 C00003618 | 2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00003617 C00003618 | 0 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00003617 C00003618 | 0 / 0 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00003617 C00003618 | 1 / 1 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00003617 C00003618 | 1 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00003617 C00003618 | 1 / 0 |
P10275 | Androgen receptor | NR3C4 | C00003617 C00003618 | 3 / 4 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00003617 C00003618 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00003617 C00003618 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00003617 C00003618 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00003617 C00003618 | 1 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00003617 C00003622 | 4 / 3 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00003617 C00003618 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00003617 C00003618 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00003617 C00003618 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00003617 C00003618 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00003617 C00003618 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00003617 C00003618 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00003617 C00003618 | 7 / 37 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003617 C00003618 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00003617 C00003618 | 0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00003617 C00003618 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00003617 C00003618 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00003618 | 0 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | C00003617 | 0 / 0 |
P21439 | Multidrug resistance protein 3 | Enzyme | C00003618 | 3 / 2 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00003618 | 0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00003618 | 1 / 1 |
P06280 | Alpha-galactosidase A | Enzyme | C00003618 | 1 / 1 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00003618 | 1 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00003622 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00003622 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00003618 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00003618 | 0 / 0 |
P46721 | Solute carrier organic anion transporter family member 1A2 | Unclassified protein | C00003618 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00003618 | 0 / 0 |
P68871 | Hemoglobin subunit beta | Secreted protein | C00003622 | 4 / 4 |
Q9NYB5 | Solute carrier organic anion transporter family member 1C1 | Unclassified protein | C00003618 | 0 / 0 |
Q86UW1 | Organic solute transporter subunit alpha | Unclassified protein | C00003618 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00003622 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003617 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00003617 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00003618 | 3 / 2 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00003618 | 0 / 0 |
P01375 | Tumor necrosis factor | Secreted protein | C00003618 | 3 / 4 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00003618 | 0 / 0 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00003618 | 1 / 0 |
Q06710 | Paired box protein Pax-8 | Unclassified protein | C00003618 | 1 / 2 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00003617
C00003618
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00003617
C00003618
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00003617
C00003618
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00003617
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00003617
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00003617
|
891 | CCNB1, CCNB | cyclin B1 |
C00003617
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00003617
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003617
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00003617
|
1111 | CHEK1, CHK1 | checkpoint kinase 1 (EC:2.7.11.1) |
C00003617
|
11200 | CHEK2, CDS1, CHK2, HuCds1, LFS2, PP1425, RAD53, hCds1 | checkpoint kinase 2 (EC:2.7.11.1) |
C00003617
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00003617
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00003617
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00003617
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00003617
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00003617
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00003617
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00003617
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00003617
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00003617
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00003617
|
10351 | ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 |
C00003618
|
9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00003618
|
6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00003618
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00003618
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00003618
|
3570 | IL6R, CD126, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ, gp80 | interleukin 6 receptor |
C00003618
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00003618
|
3757 | KCNH2, ERG1, HERG, HERG1, Kv11.1, LQT2, SQT1 | potassium voltage-gated channel, subfamily H (eag-related), member 2 |
C00003618
|
4879 | NPPB, BNP | natriuretic peptide B |
C00003618
|
6580 | SLC22A1, HOCT1, OCT1, oct1_cds | solute carrier family 22 (organic cation transporter), member 1 |
C00003618
|
6581 | SLC22A3, EMT, EMTH, OCT3 | solute carrier family 22 (organic cation transporter), member 3 |
C00003618
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00003618
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#104290 | Alternating hemiplegia of childhood 1; ahc1 |
P50993
|
#614820 | Alternating hemiplegia of childhood 2; ahc2 |
P13637
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#209950 | Atypical mycobacteriosis, familial |
P42224
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#613985 | Beta-thalassemia |
P68871
|
#603902 | Beta-thalassemia, dominant inclusion body type |
P68871
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#614162 | Candidiasis, familial, 7; candf7 |
P42224
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#614972 | Cholestasis, intrahepatic, of pregnancy 3; icp3 |
P21439
|
#602347 | Cholestasis, progressive familial intrahepatic, 3; pfic3 |
P21439
|
#114500 | Colorectal cancer; crc |
P84022
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#128235 | Dystonia 12; dyt12 |
P13637
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#600803 | Gallbladder disease 1; gbd1 |
P21439
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#140700 | Heinz body anemias |
P68871
|
#610424 | Hepatitis b virus, susceptibility to |
P01375
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#154020 | Hypomagnesemia 2, renal; homg2 |
P54710
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#218700 | Hypothyroidism, congenital, nongoitrous, 2; chng2 |
Q06710
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#611162 | Malaria, susceptibility to |
P01375
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#602481 | Migraine, familial hemiplegic, 2; fhm2 |
P50993
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive |
P42224
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#607507 | Psoriatic arthritis, susceptibility to |
P01375
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#603903 | Sickle cell anemia |
P68871
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) P68871 (marker) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00079 | Asthma |
P01375
(related)
P07550 (related) |
H00080 | Systemic lupus erythematosus |
P01375
(related)
P01375 (marker) |
H00083 | Allograft rejection |
P01375
(related)
|
H00084 | Graft-versus-host disease |
P01375
(related)
P01375 (marker) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) P68871 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) Q06710 (related) |
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00831 | Primary dystonia |
P13637
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
Q06710 (related) |
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00624 | Familial cholestasis |
P21439
(related)
|
H01213 | Gallbladder disease |
P21439
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00089 | IFN-gamma/IL-12 axis |
P42224
(related)
|
H00363 | Candidiasis |
P42224
(related)
|
H01109 | Chronic mucocutaneous candidiasis (CMC) |
P42224
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00775 | Familial or sporadic hemiplegic migraine |
P50993
(related)
|
H00998 | Alternating hemiplegia of childhood |
P50993
(related)
|
H01210 | Hypomagnesemia |
P54710
(related)
|
H00228 | Thalassemia |
P68871
(related)
|
H00229 | Sickle cell anemia (SCA) |
P68871
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D001281 | Atrial Fibrillation |
C00003616
C00003617 C00003618 |
D003866 | Depressive Disorder |
C00003617
C00003618 |
D001282 | Atrial Flutter |
C00003617
C00003618 |
D018880 | Atrial Premature Complexes |
C00003617
C00003618 |
D054537 | Atrioventricular Block |
C00003617
C00003618 |
C535438 | Bidirectional tachycardia |
C00003617
C00003618 |
D001919 | Bradycardia |
C00003617
C00003618 |
D002037 | Bundle-Branch Block |
C00003617
C00003618 |
D018879 | Ventricular Premature Complexes |
C00003617
C00003618 |
D006332 | Cardiomegaly |
C00003617
C00003618 |
D009202 | Cardiomyopathies |
C00003617
C00003618 |
D002318 | Cardiovascular Diseases |
C00003617
C00003618 |
D003221 | Confusion |
C00003617
C00003618 |
D014693 | Ventricular Fibrillation |
C00003617
C00003618 |
D003693 | Delirium |
C00003617
C00003618 |
D001145 | Arrhythmias, Cardiac |
C00003617
C00003618 |
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00003617
C00003618 |
D006323 | Heart Arrest |
C00003617
C00003618 |
D006331 | Heart Diseases |
C00003617
C00003618 |
D006333 | Heart Failure |
C00003617
C00003618 |
D018487 | Ventricular Dysfunction, Left |
C00003617
C00003618 |
D006973 | Hypertension |
C00003617
C00003618 |
D007022 | Hypotension |
C00003617
C00003618 |
D017180 | Tachycardia, Ventricular |
C00003617
C00003618 |
D053609 | Lethargy |
C00003617
C00003618 |
D013617 | Tachycardia, Supraventricular |
C00003617
C00003618 |
D012848 | Sinoatrial Block |
C00003617
C00003618 |
D012804 | Sick Sinus Syndrome |
C00003617
C00003618 |
D010554 | Personality Disorders |
C00003617
C00003618 |
D012640 | Seizures |
C00003617
C00003618 |
D008133 | Long QT Syndrome |
C00003618
|
D011660 | Pulmonary Heart Disease |
C00003617
|
D020258 | Neurotoxicity Syndromes |
C00003617
|
D009069 | Movement Disorders |
C00003617
|
C537347 | Mesenteric vascular disease |
C00003617
|
D020925 | Hypoxia-Ischemia, Brain |
C00003617
|
D013921 | Thrombocytopenia |
C00003617
|
D014202 | Tremor |
C00003617
|
D014549 | Urinary Incontinence |
C00003617
|
D020301 | Vasospasm, Intracranial |
C00003617
|
D006530 | Hepatorenal Syndrome |
C00003617
|
D003251 | Constriction, Pathologic |
C00003617
|
D002289 | Carcinoma, Non-Small-Cell Lung |
C00003617
|
D015746 | Abdominal Pain |
C00003618
|
D058186 | Acute Kidney Injury |
C00003618
|
D000370 | Ageusia |
C00003618
|
D000743 | Anemia, Hemolytic |
C00003618
|
D000787 | Angina Pectoris |
C00003618
|
D000855 | Anorexia |
C00003618
|
D001259 | Ataxia |
C00003618
|
D001321 | Autistic Disorder |
C00003618
|
D001327 | Autoimmune Diseases |
C00003618
|
D001927 | Brain Diseases |
C00003618
|
D002311 | Cardiomyopathy, Dilated |
C00003618
|
D002526 | Cerebellar Diseases |
C00003618
|
D002598 | Chagas Cardiomyopathy |
C00003618
|
D002639 | Cheyne-Stokes Respiration |
C00003618
|
D002819 | Chorea |
C00003618
|
D003072 | Cognition Disorders |
C00003618
|
D003117 | Color Vision Defects |
C00003618
|
D003128 | COMA |
C00003618
|
D003324 | Coronary Artery Disease |
C00003618
|
D003329 | Coronary Vasospasm |
C00003618
|
D003645 | Death, Sudden |
C00003618
|
D003680 | Deglutition Disorders |
C00003618
|
D003704 | Dementia |
C00003618
|
D003967 | Diarrhea |
C00003618
|
D004244 | Dizziness |
C00003618
|
D056486 | Drug-Induced Liver Injury |
C00003618
|
D062787 | Drug Overdose |
C00003618
|
D004374 | Ductus Arteriosus, Patent |
C00003618
|
D055154 | Dysphonia |
C00003618
|
D004417 | Dyspnea |
C00003618
|
D001068 | Eating Disorders |
C00003618
|
D004437 | Ebstein Anomaly |
C00003618
|
D004487 | Edema |
C00003618
|
D007172 | Erectile Dysfunction |
C00003618
|
D058447 | Eye Pain |
C00003618
|
D005221 | Fatigue |
C00003618
|
D005315 | Fetal Diseases |
C00003618
|
D006212 | Hallucinations |
C00003618
|
D006327 | Heart Block |
C00003618
|
D006505 | Hepatitis |
C00003618
|
D006947 | Hyperkalemia |
C00003618
|
D007008 | Hypokalemia |
C00003618
|
D007232 | Infant, Newborn, Diseases |
C00003618
|
D007235 | Infant, Premature, Diseases |
C00003618
|
D007859 | Learning Disorders |
C00003618
|
D012021 | Reflex, Abnormal |
C00003617
|
D008173 | Lung Diseases, Obstructive |
C00003618
|
D008275 | Magnesium Deficiency |
C00003618
|
D008569 | Memory Disorders |
C00003618
|
D001523 | Mental Disorders |
C00003618
|
D008944 | Mitral Valve Insufficiency |
C00003618
|
D019964 | Mood Disorders |
C00003618
|
D009325 | Nausea |
C00003618
|
D009369 | Neoplasms |
C00003618
|
D009410 | Nerve Degeneration |
C00003618
|
D009759 | Nystagmus, Pathologic |
C00003618
|
D000857 | Olfaction Disorders |
C00003618
|
D009901 | Optic Nerve Diseases |
C00003618
|
D010146 | Pain |
C00003618
|
D010259 | Paranoid Disorders |
C00003618
|
D011596 | Psychomotor Disorders |
C00003618
|
D011654 | Pulmonary Edema |
C00003618
|
D051437 | Renal Insufficiency |
C00003618
|
D012206 | Rhabdomyolysis |
C00003618
|
D020018 | Sexual Dysfunctions, Psychological |
C00003618
|
D013375 | Substance Withdrawal Syndrome |
C00003618
|
D013610 | Tachycardia |
C00003618
|
D013612 | Tachycardia, Ectopic Atrial |
C00003618
|
D013613 | Tachycardia, Ectopic Junctional |
C00003618
|
D013614 | Tachycardia, Paroxysmal |
C00003618
|
D016171 | Torsades de Pointes |
C00003618
|
D014277 | Trigeminal Neuralgia |
C00003618
|
D018754 | Ventricular Dysfunction |
C00003618
|
D014786 | Vision Disorders |
C00003618
|
D014839 | Vomiting |
C00003618
|
D015431 | Weight Loss |
C00003618
|